Tomoko Matsumoto

Tomoko Matsumoto

Auto-generated profile, based on publicly available information

Tomoko Matsumoto

Department of Clinical Laboratory, Tenri University, Tenri, Japan

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2020 in Haemophilia
Verified
Journal Article
Closed access
PDF file
NSNaruto Shimonishi
Naruto Shimonishi
KNKeiji Nogami
Keiji Nogami
KOKenichi Ogiwara
Kenichi Ogiwara
TMTomoko Matsumoto
Tomoko Matsumoto
FNFumie Nakazawa
Fumie Nakazawa
MSMidori Shima
Midori Shima


1 May 2004 in Journal of Orthopaedic Science
Verified
Journal Article
Closed access
PDF file
KIKenshiro Inatomi
Kenshiro Inatomi
TMTomoko Matsumoto
Tomoko Matsumoto
TTTadashi Tomonaga
Tadashi Tomonaga
MEMasao Eto
Masao Eto
HSHiroyuki Shindo
Hiroyuki Shindo
HKHiroaki Konishi
Hiroaki Konishi

1 January 2020 in Clinical and Applied Thrombosis/Hemostasis
Verified
Journal Article
Open access
PDF file
DSDaiki Shimomura
Daiki Shimomura
TMTomoko Matsumoto
Tomoko Matsumoto
KSKana Sugimoto
Kana Sugimoto
TTTokio Takata
Tokio Takata
AKAya Kouno
Aya Kouno
MKMikio Kamioka
Mikio Kamioka
Clot waveform analysis based on activated partial thromboplastin time (aPTT) is reported to be a useful assay. We attempted to find beneficial parameters with the first-derivative curve. We examined 106 plasma samples with prolonged aPTT and analyzed the first-derivative curve statistically by dividing it into 6 groups (Lupus anticoagulant, Heparin, Direct oral anticoagulants, Factor VIII inhibitor, Hepatic dysfunctions and Factor deficiency). We obtained 7 coordinates for parameter measurement by analyzing the first-derivative curve and set 20 parameters including the velocity axis, the time axis, and area parameters. The distribution was checked by extracting each parameter that showed the most significant difference in the 6 groups. As a result, it was revealed that we could classify aPTT prolongation by using a combination of 3 parameters, the initial-to-peak gradient, the ratio initial-to-intermediate velocity/intermediate-to-peak velocity, and the initial-to-peak area size. We constructed a flowchart combining these 3 parameters and were able to discriminate 75% of the specimens. These parameters derived from the first-derivative curve of clot waveform analysis are useful tools to discriminate aPTT prolongation.

10 January 2012 in Journal of Porous Materials
Verified
Journal Article
Closed access
PDF file
DHD. Huang
D. Huang
QLQinglei Liu
Qinglei Liu
YMY. Miyamoto
Y. Miyamoto
TMT. Matsumoto
T. Matsumoto
TTT. Tojo
T. Tojo
DZD. Zhang
D. Zhang

2 September 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MMMasato Matsuda
Masato Matsuda
DSDaiki Shimomura
Daiki Shimomura
TSTakeshi Suzuki
Takeshi Suzuki
YTYuka Tabuchi
Yuka Tabuchi
HKHiroshi Kurono
Hiroshi Kurono
TMTomoko Matsumoto
Tomoko Matsumoto
Activated partial thromboplastin time (APTT) prolongation occurs due to coagulation factor deficiencies/inhibitors, lupus anticoagulant (LA), and anticoagulant-taking, necessitating discrimination through further testing. Clot waveform analysis (CWA) can discriminate causes while measuring APTT, but conventional CWA exhibits moderate accuracy due to visual judgement and limited parameter use. We applied deep learning (DL) techniques to huge numerical data constituting clot waveforms and their first- and second-derivative curves (CWA curves) to leverage hidden features for developing an accurate classification model. We utilized a multi-wavelength detection system embedded in modern coagulometers to obtain multi-wavelength CWA curves. A convolutional neural network-based DL model was trained on 683 samples (135 hemophilic, 95 LA-positive, 99 heparin-treated, 105 warfarin-treated, and 249 direct oral anticoagulant-treated) and evaluated using 10-fold cross-validation. Conventional CWA parameters showed limited discrimination abilities (area under the curve [AUC] 0.532–0.858). DL models using single-wavelength CWA curves achieved higher performance (AUC 0.943–0.988), and multi-wavelength CWA curves further improved it (AUC 0.961–0.993) with high sensitivity (≥ 88.0%), specificity (> 92.0%), and overall accuracy (88.4%), although the performance may depend on reagents and/or analyzers. DL models using multi-wavelength CWA curves show promise as high-performance screening tools for classifying APTT prolongation causes and are best built in each laboratory.